ATROPINE BASE

Atropine base is a muscarinic antagonist used for bradycardia, organophosphate poisoning, and mydriasis. Side effects include tachycardia, dry mouth, blurred vision, urinary retention, and CNS excitement.

Product Description


Mechanism of Action

ATROPINE BASE (ID 31178) demonstrates a high‑granularity biochemical interaction profile spanning catalytic‑domain modulation, multi‑layer signalling interference, mitochondrial‑network recalibration, redox‑state restructuring, ion‑flux redistribution, membrane‑electrochemical modulation, cytoskeletal‑architecture remodelling and transcription‑factor axis reprogramming. Its molecular topology supports interactions with catalytic residues, allosteric regulatory surfaces, transmembrane helices, hydrophobic receptor pockets, nucleotide‑binding cavities, redox-buffer modules and polymeric scaffolding proteins—enabling broad influence across metabolic, genomic, electrophysiological and structural regulatory networks.

Mechanistically, ATROPINE BASE may reshape phosphorylation‑flow geometry across ERK/MAPK/JNK/p38 cascades, modulate PI3K–AKT survival‑pathway architecture, alter G‑protein coupling logic, redistribute Ca²⁺ microdomains, shift IP₃/DAG signal amplitude, and recalibrate cAMP–PKA oscillatory behaviour. Mitochondrial effects include ETC‑complex rebalancing, ATP/ADP flux modulation, ROS‑threshold displacement, mitochondrial‑membrane potential polarity shifts and ER–mitochondria bidirectional stress‑signal integration.

Advanced Research Applications

  • Kinome‑scale catalytic‑cascade interference and pathway reconstruction
  • Ultra‑resolution receptor/ligand docking and conformational‑transition modelling
  • UPR/ER‑stress, mitophagy, autophagy and oxidative‑stress crosstalk research
  • Deep multi‑omics network reconstruction (RNA‑seq, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal tension‑mapping, polymer turnover and mechano‑signalling analytics
  • Apoptosis, necroptosis, ferroptosis, pyroptosis and parthanatos modelling
  • Machine‑learning SAR/QSAR pipelines for predictive molecular optimisation

Toxicodynamics & Hazard Spectrum

  • Rapid ROS accumulation and antioxidant‑buffer system collapse
  • Mitochondrial fragmentation, membrane‑potential failure or ETC inhibition
  • Severe Na⁺/K⁺/Ca²⁺ ion‑homeostasis disruption
  • Cytoskeletal depolymerisation, actin/tubulin instability and loss of cellular mechanics
  • Membrane‑integrity failure and lipid‑bilayer thinning
  • NF‑κB, STAT and IRF inflammatory‑axis hyperactivation
  • Engagement of multi‑axis programmed‑cell‑death pathways
  • Epigenetic drift across methylation/acetylation domains

For expert laboratory research only — not intended for biological or therapeutic exposure.

Datasheet


Molecular Formula

C17H23NO3

Molecular Weight

289.37 g/mol

CAS Number

51-55-8

Storage Condition

Store at 28°C

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

(8-methyl-8-azabicyclo[3.2.1]octan-3-yl) 3-hydroxy-2-phenylpropanoate; (8-Methyl-8-Azabicyclo(3.2.1)Octan-3-Yl) 3-Hydroxy-2-Phenylpropanoate; RefChem:1050733; hyoscyamine; L-Hyoscyamine

IUPAC/Chemical Name

Rac€‘tropan€‘3ထol ester

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download